Results 251 to 260 of about 610,115 (295)
ABSTRACT Nodal follicular helper T‐cell (TFH) lymphoma of the angioimmunoblastic (AITL) subtype has a dismal prognosis. Using whole‐exome sequencing (n = 124), transcriptomic (n = 78), and methylation (n = 40) analysis, we identified recurrent mutations in known epigenetic drivers (TET2, DNMT3A, IDH2R172) and novel ones (TET3, KMT2D).
Alyssa Bouska+43 more
wiley +1 more source
Isolated thrombocytopenia as the initial manifestation of childhood-onset systemic lupus erythematosus: A case report. [PDF]
Abunejma FM+6 more
europepmc +1 more source
ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder classified into three recognized clinical subtypes—idiopathic plasmacytic lymphadenopathy (IPL), TAFRO, and NOS. Although clinical criteria are available for subtyping, diagnostically challenging cases with overlapping histopathological features highlight ...
Midori Filiz Nishimura+14 more
wiley +1 more source
The 'autoimmunome' of centenarians. [PDF]
Carrera-Bastos P+10 more
europepmc +1 more source
ABSTRACT Uniparental disomy (UPD) is a rare phenomenon in which both copies of a chromosome are inherited from a single parent. This can lead to genomic imprinting disorders and recessive disorders due to the presence of recessive pathogenic variants in both alleles. Additionally, depending on the mechanisms by which UPD occurs, mosaic aneuploidies may
Marta Carreño‐Hidalgo+4 more
wiley +1 more source
Diffuse Alveolar Hemorrhage as the First Presentation of Systemic Lupus Erythematosus: A Case Report. [PDF]
Later S+6 more
europepmc +1 more source
Cardiovascular Health, Genetic Susceptibility, and the Risk of Incident Autoimmune Disorders in the UK Biobank: A Prospective Cohort Study. [PDF]
Lin L+8 more
europepmc +1 more source
Diagnosis of rheumatic and autoimmune diseases dataset. [PDF]
Mahdi MF, Jahani A, Abd DH.
europepmc +1 more source
Systemic lupus erythematosus as the paradigm for understanding the complex immune relationships and therapeutic opportunities for targeting complement in autoimmune diseases. [PDF]
Holers VM.
europepmc +1 more source